Agios Pharmaceuticals
- Market cap
- 1.90B
- P/E (TTM)i
- -4.53
- P/Bi
- 1.85
- EPSi
- -7.12
- Div yieldi
- 0.00%
- 52W posi
- 40%
Anonymous reader poll. Unscientific, not investment advice.
Agios Pharmaceuticals ended the session at 31.79, up 0.22%. The company carries a market value of roughly 1.90B, the #2841 most valuable US-listed company we track. Across 6 analysts the consensus rating is Buy, with an average price target of 52.33 (+65%). The shares sit 40% of the way up their 52-week range of 22.24 to 46.00.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 months.
- Recent price momentum is -25.0% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 12.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 31.72
- Open
- 31.37
- Day range
- 31.07 - 32.27
- Avg price
- 31.80
- Volume
- 1.67M
- Turnover
- 53.21M
- Turnover ratei
- 3.35%
- Volume ratioi
- 1.32
- Amplitudei
- 3.78%
- 52-week rangei
- 22.24 - 46.00
Valuation
- P/Ei
- -4.46
- P/E (TTM)i
- -4.53
- P/Bi
- 1.85
- EPSi
- -7.12
- Book value / shi
- 17.19
- Net profit
- -425.08M
- Net assets
- 1.03B
Share structure
- Market cap
- 1.90B
- Float capi
- 1.59B
- Shares out
- 59.70M
- Float sharesi
- 50.02M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
30.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+2.67M net over the window
Short interest
- Shares short
- 7.56M
- % of floati
- 12.66%
- Days to coveri
- 9.46
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Agios Pharmaceuticals (AGIO)?
Agios Pharmaceuticals last traded at 31.79. The quote on this page refreshes every few seconds while US markets are open.
What is Agios Pharmaceuticals's market cap?
About 1.90B.
What is the P/E ratio of Agios Pharmaceuticals?
The trailing twelve-month P/E is -4.53. The Valuation tab shows it against the stock's own five-year range.
Does Agios Pharmaceuticals pay a dividend?
Agios Pharmaceuticals does not currently pay a regular dividend.
Is Agios Pharmaceuticals a buy according to analysts?
The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 52.33, which implies 64.6% upside from the current price. This is not investment advice.
What is Agios Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Agios Pharmaceuticals a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.